Dossier · RKLB · Recently exited
RKLB · Rocket Lab Corporation · Stock research
Last analysed ·
Current thesis
Defense-backlog re-fire interrupts the mid-July rollover: the 7/20 $17B NSSL Phase 3 Lane 1 qualification and 7/21 $266M suborbital award stabilized the tape after the 7/13 support break and Piper's 7/16 Neutral $83 cap. An unresolved $3.6B bridge + $3B ATM dilution overhang and a ~8/7 Q2 binary sit under any fresh entry; maturing theme bouncing off a broken structure, confirm rather than chase.
Invalidation trigger
A weekly close below $105 loses the post-Iridium deal base and hands the tape back to the pre-announcement range; a $3B-ATM equity take-out of the $3.6B bridge, or space-ETF (UFO/FSPC) inflows rolling over as NSSL task orders fail to convert, would remove the remaining passive and backlog bid.
Thesis status
Invalidated resolved published trigger fired graded at medium · since re-rated low How this is scored →Latest analysis and events for RKLB —
As of 2026-08-05, orbyd's latest analysis for Rocket Lab Corporation (RKLB): Note of 2026-07-16: Piper Sandler initiated Neutral, PT $83 — FIRST post-Iridium coverage launch and it landed BELOW spot and below the entire 6-raise June 30 cluster ($96 Cantor floor, $130 Citizens/Roth ceiling). Target band now brackets price instead of sitting above it. A second Neutral or a downgrade from an existing bull confirms the raise cycle is over.
Invalidation trigger: A weekly close below $105 loses the post-Iridium deal base and hands the tape back to the pre-announcement range; a $3B-ATM equity take-out of the $3.6B bridge, or space-ETF (UFO/FSPC) inflows rolling over as NSSL task orders fail to convert, would remove the remaining passive and backlog bid.
Next dated event on file: — catalyst in 1d.
Current Thesis
Award flow re-attached to price this week. Shares closed $74.48 on 2026-08-04, up 5.75% on 19.4M shares — a second consecutive advance after the 2026-08-03 session that ran from a $62.17 intraday low to a $70.43 close. After the 2026-08-04 U.S. close the Space Force named Rocket Lab to a $397M contract under the Space-Based Airborne Moving Target Indicator program; shares added roughly 3% in extended trade. That is $663M of announced defense work inside nine sessions — $266M of suborbital HASTE launches on 2026-07-27, SB-AMTI on 2026-08-04 — against a tape that fell more than 9% on 2026-07-28 while digesting the first of them.
The leg on offer is a vertically integrated launch and space-systems prime whose defense book is compounding faster than its equity: Q1 FY2026 revenue $200.3M, +63.5% YoY, backlog $2.2B, market cap $44.55B at the 2026-08-04 close, 50% below the $150.23 close of 2026-05-27. What the week did not change is the conversion problem. The SB-AMTI Flatellites are contracted to fly on Neutron. NSSL Phase 3 Lane 1 eligibility, qualified 2026-07-20, is likewise Neutron-gated. Contract value keeps stacking on a vehicle that has not flown and whose debut has slipped from 2025, then from mid-2026, and is now targeted for Q4 2026 after the January Stage 1 tank rupture at Wallops.
Structurally the stock is still below its references: 200-day $77.82 and 50-day $94.46 at 2026-08-04, roughly 4.5% and 27% overhead, with the 50-day falling ($95.48 the prior session). Three dated events sit inside five sessions of publication — the 2026-08-06 SpaceX lockup, the 2026-08-10 Q2 print with about a 17% move priced into options, and whatever follow-through the SB-AMTI award does or does not produce.
Bullish and bearish views on Rocket Lab Corporation
The model's bull view on Rocket Lab Corporation (RKLB), in brief: 2026-08-04 (post-close): $397M SB-AMTI award — develop, launch and operate multiple Flatellites carrying space-based sensors and low-latency, high-bandwidth links, launched on Neutron and operated from secure facilities, with an option for additional satellites inside the stated… The bear view: Neutron has not flown, and both marquee defense wins convert only afterward. Both cases follow in full.
Bull Case
- 2026-08-04 (post-close): $397M SB-AMTI award — develop, launch and operate multiple Flatellites carrying space-based sensors and low-latency, high-bandwidth links, launched on Neutron and operated from secure facilities, with an option for additional satellites inside the stated value. Part of $615M the Space Force split across Rocket Lab, Systems & Technology Research and a third provider.
- 2026-07-27: $266M firm-fixed-price Space Force award — 12 suborbital HASTE launches through 2028 with options for six more, staged primarily from Kodiak, first mission no earlier than late 2026.
- 2026-07-30: iQPS booked three more dedicated Electron flights from Launch Complex 1 beginning late 2027, its third multi-launch order, taking contracted Electron missions with that customer to 18.
- 2026-05-07: Q1 FY2026 revenue $200.3M, +63.5% YoY against $190.9M consensus; backlog $2.2B, +20.2% QoQ; cash and marketable securities $1.48B.
- 2026-08-04: SpaceX's first public quarter put a filed number under the sector's demand assumption — revenue $7.8B, +92% YoY against roughly $6.72B consensus, adjusted EBITDA $3.5B against roughly $2.0B, Starlink at 12 million subscribers with 1.7M net adds.
- 2026-08-04: Clear Street reiterated Buy at $129. The 18-analyst consensus is Buy with a $111.31 average target, range $64 to $150, no Sell ratings.
- 2026-04-14: the Mynaric acquisition closed, bringing laser optical terminals in-house. Inferred, not stated by the company: SB-AMTI's low-latency, high-bandwidth link requirement maps onto that capability — the award release does not name Mynaric.
- 2026-06-22: Nasdaq-100 membership effective, attaching a slice of index flow indifferent to the drawdown.
Bear Case
- Neutron has not flown, and both marquee defense wins convert only afterward. The 2026-05 stage-one tank redesign followed the January rupture; the Q4 2026 window is the third one management has named.
- 2026-07-28: shares fell more than 9% while digesting the largest launch contract in company history. As of publication the 2026-08-04 award has not had a full follow-through session, so whether headlines transmit to price again is unresolved.
- Price sits under both major averages — 200-day $77.82, 50-day $94.46 at 2026-08-04 — and the 50-day is declining.
- 2026-08-06: SpaceX's first lockup tranche releases 911.5M shares unconditionally, roughly $123B at recent prices. Reported schedule has 7% tranches every two to four weeks from August into October, roughly 28% at Q3 earnings and the remainder on 2026-12-08. Sector supply is staggered through year-end.
- 2026-08-04: SPCX rose 9.43% to $125.33 in the regular session then reversed 8.56% to about $114.60 after hours on $18.37B of quarterly capex against a $13.22B FactSet consensus, with management guiding similar levels for the rest of the year.
- The $3B ATM prospectus supplement dated 2026-05-20 remains live, and the $3.6B 364-day senior secured bridge from Deutsche Bank and Wells Fargo funding the Iridium cash leg has no publicly named take-out. Shares outstanding were 598.18M against a 557.16M float at 2026-08-04.
- Price has not returned to the top of that band.
- Piper Sandler's mid-July Hold at $83 is the lowest 2026 initiation and still sits above the 2026-08-04 close. The $64 low target in the current 18-analyst range implies about 14% downside from that close.
- 2026-08-04 coverage described SpaceX prioritising Starlink payloads on its own vehicles and squeezing third-party manifests. That reads as an opening for the other US medium-lift entrant only once Neutron is flying.
Setup & Price Structure
Close $74.48 on 2026-08-04, +$4.05 (+5.75%), volume 19.4M. The 52-week range is $37.57 to $151.00; the all-time closing high was $150.23 on 2026-05-27, leaving the stock 50.4% below it. Market cap $44.55B on 598.18M shares outstanding, TTM revenue $679.58M (+45.8%).
Overhead references at 2026-08-04: 200-day $77.82, 50-day $94.46. Underneath, $67.50 is the level at which the Iridium exchange ratio stops floating; it was reclaimed on 2026-08-03 and spot sits about 10% above it. The 2026-08-03 low of $62.17 is the reversal shelf.
Positioning observables rather than a verdict on them: short interest 45.85M shares, 8.23% of a 557.16M float, up from 42.60M the prior month, at 1.71 days to cover, with a five-year beta of 2.63 — the short book grew into the decline. Retail-facing coverage clustered heavily on the same move, with daily posts running from 2026-07-26 through 2026-08-03 on drawdown, oversold signals and contract headlines. The earnings date is four sessions out with options implying about a 17% move against a 10.4% average across the prior four quarters. A $3B equity shelf sits live, and insider trust sales completed in early July at prices above spot. Distance above a rising moving average is not the crowding condition here — price is below two declining ones.
Life-cycle: MATURING. The attention is mainstream and index-level (Nasdaq-100 effective 2026-06-22, 18 covering analysts), and the flow has moderated from the May peak, yet the narrative still produces headlines that move price — 2026-07-27 and 2026-08-04 both drew bids. It is not SATURATED: the May-to-July drawdown removed the late bid and short interest rose to 8.23% of float rather than falling. It is not DEAD either: backlog, awards and revenue growth are all still compounding, and the 200-day is being retested from below. What is broken is the price structure, dating to the 2026-07-13 support break, not the story.
Catalyst Calendar (next 30 days)
- 2026-08-10 — Q2 FY2026 results after the U.S. close, call 2:00 p.m. PT. Guidance $225–240M revenue, GAAP gross margin 33–35%, non-GAAP 38–40%, adjusted EBITDA loss $20–26M; consensus near $231.6M and about a $0.06 loss per share.
- ~2026-08-15 (est.) — NASA Aspera on Electron from Launch Complex 1A, Mahia, into sun-synchronous orbit.
- ~2026-08-20 (est.) — second SpaceX lockup tranche under the reported 7%-every-two-to-four-weeks cadence.
Outside the 30-day window but dated: the Neutron debut attempt (~2026-Q4, est.) and the Form S-4 carrying the Iridium shareholder-vote date (~2026-H2, est.), against a mid-2027 targeted close and a 2027-06-28 outside date.
Elapsed catalysts
- 2026-08-06 — SpaceX first IPO lockup tranche: 911.5M shares unconditional, roughly $123B at recent prices. Sets listed-space supply two sessions before Rocket Lab reports. (passed 3d ago)
- 2026-08 through 2026-09 (ongoing) — 8-K and 424B5 filings disclosing issuance under the $3B ATM dated 2026-05-20. (passed 81d ago)
What Would Change Our Mind
The entire leg rests on one convertibility claim — that defense awards signed against Neutron become revenue. The single datapoint that breaks it is the 2026-08-10 call passing with no dated debut milestone: no hot-fire date, no first-launch window, after two prior slips. A third slip announced on that call would mean the $397M SB-AMTI award and NSSL Lane 1 eligibility are backlog with no clock on them.
On price, a weekly close below $67.50 gives back the 2026-08-03 reversal, re-pins the Iridium exchange ratio at its 0.4000 maximum and returns the tape to the pre-announcement range.
Other conditions that would change the read: management naming equity as the take-out path for the $3.6B bridge, or a 424B5 disclosing heavy ATM sales at these levels; UFO closing back under roughly $41 after the 2026-08-06 unlock, which would say the sector bid is not recovering; a second post-award session closing lower, repeating 2026-07-28; any target cut below Piper Sandler's $83.
The opposite case also has a shape. A dated Neutron static fire plus Q2 revenue above the $240M top of guidance would argue the mid-July break was a sector de-rating rather than a company-specific one, and would put the $77.82 200-day into play as support instead of resistance.
Correlation Notes
- SPCX is the price-setter for the complex right now, holding both the 2026-08-04 earnings and the 2026-08-06 unlock. Over the month to 2026-07-31 the group moved as one: RKLB -36%, SpaceX -36%, AST SpaceMobile -34%, Planet Labs -38%, Intuitive Machines -43%.
- The Procure Space ETF (UFO) traded $45.78 on 2026-08-03, off roughly $41 at the 2026-07-31 trough and well below a 52-week high near $68, while still up 53.53% year to date. Sector-level flow, not single-name news, drove most of July.
- Nasdaq-100 membership since 2026-06-22 attaches part of the float to broad index flow that ignores the drawdown.
- IRDM is mechanically linked: consideration is $27.00 cash plus a collared ratio pinned at 0.4000 below a $67.50 10-day VWAP and 0.2400 above $112.50, so RKLB's own price is an input to the deal's value to Iridium holders.
- Watch whether RKLB decouples from SPCX around 2026-08-06. Two Space Force awards in nine sessions push the name toward defense-budget beta and away from pure listed-space beta; the unlock session is the cleanest test of that available before the print.
Notes
- 2026-04-18: seed: Serenity/attention list
- 2026-05-20: $3B ATM equity program filed with 16 banks — discretionary supply ceiling near record highs; this is a NEW structural negative the original re-entry gate did not price. Track 8-K/424B5 for actual issuance volume.
- 2026-06-05: S&P declined to create a SpaceX index-inclusion catalyst — removes the speculation bid the proxy basket front-ran; space complex crashed on the news.
- 2026-07-16: Piper Sandler initiated Neutral, PT $83 — FIRST post-Iridium coverage launch and it landed BELOW spot and below the entire 6-raise June 30 cluster ($96 Cantor floor, $130 Citizens/Roth ceiling). Target band now brackets price instead of sitting above it. A second Neutral or a downgrade from an existing bull confirms the raise cycle is over.
- Neutron has not flown. Every NSSL Lane 1 and SB-AMTI revenue assumption depends on a debut targeted for Q4 2026 after the January Stage 1 tank rupture at Wallops.
- The $3B ATM prospectus supplement dated 2026-05-20 remains live. Actual issuance surfaces only in 8-K and 424B5 filings, never in press releases.
- The $17B NSSL Phase 3 Lane 1 figure is a shared IDIQ ceiling across several providers, not a Rocket Lab award; task orders are the conversion measure.
- Iridium consideration is $27.00 cash plus a collared exchange ratio: 0.4000 shares below a $67.50 RKLB 10-day VWAP, 0.2400 above $112.50. Outside date 2027-06-28.
- The Iridium cash leg is funded by a $3.6B 364-day senior secured bridge from Deutsche Bank and Wells Fargo, so interest expense precedes any recurring-revenue contribution.
- Company communication goes quiet in the blackout window ahead of each quarterly release, so financing and schedule news tends to surface in the release itself.
Related · shared themes
IRDM
Iridium Communications Inc
Deal-arb discount narrowed to 7.5%: RKLB closed $82.83 on 2026-08-07, $15.33 inside the collar's flat band, so the package still marks $54.00 against IRDM's $49.93. Forty days post-announcement there is still no Form S-4, no FCC docket and no disclosed HSR expiry. Rocket Lab's 2026-08-10 print is the next dated input.
SPCX
SpaceX (Space Exploration Technologies Corp.)
Both binaries cleared: the first-ever print beat on revenue and EPS (2026-08-04), then 911.5M shares unlocked 2026-08-06 without a wall — low $105.11, close $114.92 (+6.14%). What replaces them is $18.37B quarterly capex against ~$13.2B consensus and a lock-up drip resuming ~2026-08-12.
ASTS
AST SpaceMobile, Inc.
Reclaim leg running straight into the binary: 2026-08-03 +8% to $63.52 on Meta's WhatsApp-over-BlueBird workshop, 2026-08-04 +10.69% to $70.31 into the launch. BlueBirds 11-13 flew 2026-08-05; the 2026-08-10 Q2 call is the test — $14.7M booked in Q1 against a $150-200M FY26 guide, 13 satellites against ~45 targeted.
PL
Planet Labs PBC
The $19.16–$19.83 shelf held eight sessions and PL gapped out of it on 8/4 to close $22.83, the highest since 7/21 — but both up days came on sector beta with no company news, on below-average volume. SpaceX's debut print beat on revenue and shocked on $18.4B capex; up to 911.5M shares unlock 8/6.
See also · stocks to watch